Application value of dual bioelectrical impedance analysis in detecting visceral fat area in patients with type 2 diabetes mellitus
WU Jin-zhi1 ZHENG Gui-an2▲ LAI Peng-bin1 XIE Liang-xiao1 ZHA Xiao-yun1
1.Department of Endocrinology, Zhangzhou Hospital Affiliated to Fujian Medical University, Fujian Province,Zhangzhou 363000, China;
2.Department of Cardiology, Zhangzhou Hospital Affiliated to Fujian Medical University,Fujian Province, Zhangzhou 363000, China
Abstract：Objective To investigate the application value of dual bioelectrical impedance analysis (dBIA) in detecting visceral fat area (VFA) in patients with type 2 diabetes mellitus (T2DM).Methods From January 2017 to January 2019,128 patients with T2DM were selected from the department of endocrinology of our hospital.The blood biochemical analysis was performed and the history of hypertension and/or dyslipidemia was recorded.According to brain natriuretic peptide (BNP) level, the patients were divided into the BNP≥100 pg/ml group and the BNP＜100 pg/ml group.VFA was measured using dBIA and computed tomography (CT) on the same day.Pearson′s correlation analysis was used to detect the relationship between VFA measured by dBIA (VFA-dBIA) and VFA measured by CT (VFA-CT).Multiple regression analysis was performed to detect multiple factors related to measurement error of VFA.The receiver operating characteristic (ROC) analysis for the VFA was used to detect the presence of comorbid hypertension and/or dyslipidemia with T2DM.The areas under the curve (AUC) were also calculated and compared.Results The percent measurement error between VFA-dBIA and VFA-CT in the BNP ≥100 pg/ml group was significantly higher than that in the BNP＜100 pg/ml group ([39.2±8.1]% vs.[24.1±6.4]%, P=0.031).After excluding patients with BNP≥100 pg/ml, the VFA-dBIA was significantly correlated with the VFA-CT (r=0.917, P＜0.0001).The AUC in the ROC analysis for the VFA-dBIA to detect the presence of comorbid hypertension and/or dyslipidemia with T2DM was almost equivalent to that for the VFA-CT.Conclusion In patients with T2DM without potential heart failure, estimation of the VFA-dBIA significantly correlates with VFA-CT, and VFA-dBIA has the same diagnostic efficacy as VFA-CT in identifying diabetes mellitus with comorbid hypertension and/or dyslipidemia.
Jastreboff AM，Kotz CM，Kahan S，et al.Obesity as a disease：the obesity society 2018 position statement[J].Obesity，2019，27（1）：7-9.
[2]
Lyall DM，Celis-Morales C，Ward J，et al.Association of body mass index with cardiometabolic disease in the UK Biobank：a Mendelian randomization study[J].JAMA Cardiol，2017，2（8）：882-889.
[3]
Meldrum DR，Morris MA，Gambone JC.Obesity pandemic：causes，consequences，and solutions-but do we have the will?[J].Fertil Steril，2017，107（4）：833-839.
[4]
Tanaka T，Kishi S，Ninomiya K，et al.Impact of abdominal fat distribution，visceral fat，and subcutaneous fat on coronary plaque scores assessed by 320-row computed tomography coronary angiography[J].Atherosclerosis，2019，287：155-161.
[5]
Rodriguez-Granillo GA，Reynoso E，Capunay C，et al.Pericardial and visceral，but not total body fat，are related to global coronary and extra-coronary atherosclerotic plaque burden[J].Int J Cardiol，2018，260：204-210.
[6]
Asano T，Kubota N，Koizumi N，et al.Novel and simple ultrasonographic methods for estimating the abdominal visceral fat area[J].Int J Endocrinol，2017，2017：8796069.
Park KS，Lee DH，Lee J，et al.Comparison between two methods of bioelectrical impedance analyses for accuracy in measuring abdominal visceral fat area[J].J Diabetes Complications，2016，30（2）：343-349.
Ida M，Hirata M，Odori S，et al.Early changes of abdominal adiposity detected with weekly dual bioelectrical impedance analysis during calorie restriction[J].Obesity （Silver Spring），2013，21（9）：E350-E353.
[12]
Hise ACDR，Gonzalez MC.Assessment of hydration status using bioelectrical impedance vector analysis in critical patients with acute kidney injury[J].Clin Nutr，2018，37（2）：695-700.
[13]
Yancy CW，Jessup M，Bozkurt B，et al.2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure：a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America[J].Circulation，2017，136（6）：e137-e161.
[14]
Giordano A，Frontini A，Cinti S，et al.Convertible visceral fat as a therapeutic target to curb obesity[J].Nat Rev Drug Discov，2016，15（6）：405-424.
[15]
Cheung AS，de Rooy C，Hoermann R，et al.Correlation of visceral adipose tissue measured by Lunar Prodigy dual X-ray absorptiometry with MRI and CT in older men[J].Int J Obes （Lond），2016，40（8）：1325-1328.
[16]
Gómez-Ambrosi J，González-Crespo I，Catalán V，et al.Clinical usefulness of abdominal bioimpedance （ViScan）in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities[J].Clin Nutr，2018，37（2）：580-589.
[17]
Bosy-Westphal A，Jensen B，Braun W，et al.Quantification of whole-body and segmental skeletal muscle mass using phase-sensitive 8-electrode medical bioelectrical impedance devices[J].Eur J Clin Nutr，2017，71（9）：1061-1067.
[18]
Lee JJ，Pedley A，Hoffmann U，et al.Association of changes in abdominal fat quantity and quality with incident cardiovascular disease risk factors[J].J Am Coll Cardiol，2016，68（14）：1509-1521.
[19]
Sato F，Maeda N，Yamada T，et al.Association of epicardial，visceral，and subcutaneous fat with cardiometabolic diseases[J].Circ J，2018，82（2）：502-508.
[20]
Sullivan CA，Kahn SE，Fujimoto WY，et al.Change in intraabdominal fat predicts the risk of hypertension in Japanese Americans[J].Hypertension，2015，66（1）：134-140.
京公网安备 11010502046607号